Jyothy Labs revenue rises 3.5% to ₹2,944 crore in FY26

1 min read Updated on 19 Jun 2026, 02:35 PM

Reviewed by

Suketu GScanX News Team

AI Summary

Jyothy Labs Limited reported a 3.5% rise in revenue to ₹2,944 crore for FY26, while PAT declined to ₹333 crore. Operating EBITDA stood at ₹450 crore.

*this image is generated using AI for illustrative purposes only.

Jyothy Labs Limited reported a 3.5% increase in revenue to ₹2,944 crore for the financial year ended March 31, 2026, compared to ₹2,844 crore in the previous year. The company’s profit after tax (PAT) declined to ₹333 crore from ₹371 crore in the same period.

Operating EBITDA stood at ₹450 crore, representing a margin of 15.3%, down from 17.6% in the previous year. The company maintained a strong financial position with zero debt and a cash and bank balance of ₹997 crore as of March 31, 2026.

The Board of Directors has recommended a final dividend of ₹3.50 per equity share of ₹1 each for the financial year 2025-26. The proposed dividend payout totals ₹12,853 lakh and is subject to shareholder approval at the upcoming Annual General Meeting.

Financial Performance Summary

Metric (₹ in Crore)	FY 2025-26	FY 2024-25
Revenue from Operations	2,944	2,844
Profit After Tax	333	371
Operating EBITDA	450	500
Cash and Bank Balances	997	757
Net Worth	1,589	1,383

The Fabric Care segment led the growth, increasing by 8.1% in value and 9.5% in volume. The Dishwashing segment saw a marginal value decline of 1.3% despite volume growth, while the Personal Care segment grew by 5.2%. The Household Insecticide segment reduced its EBIT losses from ₹25 crore in FY25 to about ₹5 crore in FY26.

Historical Stock Returns for Jyothy Laboratories

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.82%	+1.15%	-5.87%	-28.70%	-39.63%	+31.44%

What strategic initiatives will Jyothy Labs implement to reverse the decline in operating EBITDA margins?

How does the company plan to utilize its substantial cash reserves of ₹997 crore for future growth or acquisitions?

Is the reduction in EBIT losses within the Household Insecticide segment sustainable, and when is profitability expected?

Read Next Article

Jyothy Labs shares analyst call recording on Pril and Fa brand exit

1 min read Updated on 19 Jun 2026, 12:11 AM

Reviewed by

Ashish TScanX News Team

Add as a preferred
source on Google

AI Summary

Jyothy Labs released the audio recording of the analyst call held on June 18, 2026, to discuss the Pril and Fa brand license exit. The company is pursuing legal remedies against Henkel AG & Co. KGaA to assert contractual rights under agreements executed on May 31, 2011.

*this image is generated using AI for illustrative purposes only.

Jyothy Labs Limited has released the audio recording of the conference call held on June 18, 2026, to discuss updates regarding the Pril and Fa brand license agreements. The recording is available for download following the company's earlier announcement on June 15, 2026, regarding its decision to pursue legal remedies against Henkel AG & Co. KGaA. The company aims to assert its contractual rights concerning the exit and transition mechanism under the License Agreements and Technology License Agreements executed on May 31, 2011.

Agreement Details

The License Agreements and Technology License Agreements involve Erstwhile Henkel India Limited, which has since amalgamated with Jyothy Labs Limited, and Henkel AG & Co. KGaA. These agreements cover the manufacturing, distribution, marketing, and sale of products under the Pril and Fa brands. The key details of the agreement are outlined below:

Sr. No	Particulars	Details
A	Name of parties to the Agreement	Erstwhile Henkel India Limited (since amalgamated with Jyothy Labs Limited) and Henkel AG & Co. KGaA
B	Nature of the Agreement	License Agreements and Technology License Agreements for manufacturing, distribution, marketing and sale under Pril and Fa brands
C	Date of execution of the Agreement	May 31, 2011
D	Details of termination and impact	Subsequent to discussions and communication from Henkel, the Company has evaluated all available options and concluded to pursue appropriate legal remedies

Regulatory Disclosure

The disclosure was submitted to BSE Limited and the National Stock Exchange of India Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shreyas Parag Trivedi, Head – Legal & Company Secretary, signed the disclosure on behalf of the company. Jyothy Labs stated that it will keep the stock exchanges informed of any further material developments.

Historical Stock Returns for Jyothy Laboratories